Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Signaling pathways in the epithelial origins of pulmonary fibrosis.

Hardie WD, Hagood JS, Dave V, Perl AK, Whitsett JA, Korfhagen TR, Glasser S.

Cell Cycle. 2010 Jul 15;9(14):2769-76. Epub 2010 Jul 3. Review.

2.

The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells.

Yamada M, Kubo H, Ota C, Takahashi T, Tando Y, Suzuki T, Fujino N, Makiguchi T, Takagi K, Suzuki T, Ichinose M.

Respir Res. 2013 Sep 24;14:95. doi: 10.1186/1465-9921-14-95.

3.

TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease.

Willis BC, Borok Z.

Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L525-34. Epub 2007 Jul 13. Review.

4.

Sphingolipids in pulmonary fibrosis.

Huang LS, Natarajan V.

Adv Biol Regul. 2015 Jan;57:55-63. doi: 10.1016/j.jbior.2014.09.008. Epub 2014 Oct 13. Review.

5.

Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway.

Chen T, Nie H, Gao X, Yang J, Pu J, Chen Z, Cui X, Wang Y, Wang H, Jia G.

Toxicol Lett. 2014 Apr 21;226(2):150-62. doi: 10.1016/j.toxlet.2014.02.004. Epub 2014 Feb 12.

PMID:
24530353
6.

Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis.

Tanjore H, Xu XC, Polosukhin VV, Degryse AL, Li B, Han W, Sherrill TP, Plieth D, Neilson EG, Blackwell TS, Lawson WE.

Am J Respir Crit Care Med. 2009 Oct 1;180(7):657-65. doi: 10.1164/rccm.200903-0322OC. Epub 2009 Jun 25.

7.

Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.

Yamashita CM, Dolgonos L, Zemans RL, Young SK, Robertson J, Briones N, Suzuki T, Campbell MN, Gauldie J, Radisky DC, Riches DW, Yu G, Kaminski N, McCulloch CA, Downey GP.

Am J Pathol. 2011 Oct;179(4):1733-45. doi: 10.1016/j.ajpath.2011.06.041. Epub 2011 Aug 24.

8.

TGF-β activation and lung fibrosis.

Tatler AL, Jenkins G.

Proc Am Thorac Soc. 2012 Jul;9(3):130-6. doi: 10.1513/pats.201201-003AW.

PMID:
22802287
9.

Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.

Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T.

J Surg Res. 2015 Jul;197(1):167-75. doi: 10.1016/j.jss.2015.02.062. Epub 2015 Mar 13.

PMID:
25911951
10.

Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.

Senoo T, Hattori N, Tanimoto T, Furonaka M, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Yokoyama A, Kohno N.

Thorax. 2010 Apr;65(4):334-40. doi: 10.1136/thx.2009.119974.

PMID:
20388759
11.

Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.

Myllärniemi M, Lindholm P, Ryynänen MJ, Kliment CR, Salmenkivi K, Keski-Oja J, Kinnula VL, Oury TD, Koli K.

Am J Respir Crit Care Med. 2008 Feb 1;177(3):321-9. Epub 2007 Nov 1.

12.

Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.

Korfhagen TR, Le Cras TD, Davidson CR, Schmidt SM, Ikegami M, Whitsett JA, Hardie WD.

Am J Respir Cell Mol Biol. 2009 Nov;41(5):562-72. doi: 10.1165/rcmb.2008-0377OC. Epub 2009 Feb 24.

13.

Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis: exaggerated response to alveolar epithelial injury in a novel mouse model.

Hoyles RK, Khan K, Shiwen X, Howat SL, Lindahl GE, Leoni P, du Bois RM, Wells AU, Black CM, Abraham DJ, Denton CP.

Arthritis Rheum. 2008 Apr;58(4):1175-88. doi: 10.1002/art.23379. Erratum in: Arthritis Rheum. 2015 Oct;67(10):2741.

14.

Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts.

Sheppard D.

Ann Am Thorac Soc. 2015 Mar;12 Suppl 1:S21-3. doi: 10.1513/AnnalsATS.201406-245MG. Review.

15.

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA, Piguet PF, Vassalli P.

J Clin Invest. 1995 Jul;96(1):250-9.

16.

The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.

Sides MD, Klingsberg RC, Shan B, Gordon KA, Nguyen HT, Lin Z, Takahashi T, Flemington EK, Lasky JA.

Am J Respir Cell Mol Biol. 2011 Jun;44(6):852-62. doi: 10.1165/rcmb.2009-0232OC. Epub 2010 Aug 6.

17.

Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis.

Li M, Krishnaveni MS, Li C, Zhou B, Xing Y, Banfalvi A, Li A, Lombardi V, Akbari O, Borok Z, Minoo P.

J Clin Invest. 2011 Jan;121(1):277-87. doi: 10.1172/JCI42090. Epub 2010 Dec 6.

18.

Epithelial origin of myofibroblasts during fibrosis in the lung.

Willis BC, duBois RM, Borok Z.

Proc Am Thorac Soc. 2006 Jun;3(4):377-82. Review.

19.

Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis.

Fujita H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, Hara A, Amenomori M, Ishimoto H, Nagata T, Mukae H, Kohno S.

Respiration. 2011;81(5):420-30. doi: 10.1159/000324080. Epub 2011 Apr 19.

20.

Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice.

Korfhagen TR, Swantz RJ, Wert SE, McCarty JM, Kerlakian CB, Glasser SW, Whitsett JA.

J Clin Invest. 1994 Apr;93(4):1691-9.

Supplemental Content

Support Center